Governance GC Genome Corporation

A340450

KR7340450006

Healthcare Facilities & Services

End-of-day quote Korea S.E. 2026-09-23			5-day change	1st Jan Change
8,180.00 ^KRW	+12.21%		+16.86%	+19.94%

12-09	GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy	CI
25-06-12	GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut	MT

Executive Committee: GC Genome Corporation

Manager

Positions heldSince

Chang-Seok Gi

57 year

Chief Executive Officer

2020-03-25

Sang-Hun Jeong

50 year

Director of Finance/CFO

2025-03-26

Seu-Nga Hyun

45 year

Comptroller/Controller/Auditor

2024-03-28

Composition of the Board of Directors: GC Genome Corporation

Director

CommitteesSince

Sang-Uk Kim

57 year

Director/Board Member	2023-03-29
Independent Dir/Board Member	2023-03-29

Former Officers and Directors: GC Genome Corporation

Insider	Positions held SinceUntil

Age distribution of managers

Parity Men Women

Male	5
Female	0

Of which Executive Committee

Male	3
Female	0

Of which Directors

Male	1
Female	0

GC Genome Corp is a Korea-based company principally engaged in the provision of genome testing and analysis services. The Company is principally engaged in the provision of prenatal and newborn screening genetic testing services, cancer patient precision diagnosis genetic testing services, precision diagnosis genetic testing service for patients with rare diseases, health checkup test services as well as others.

Employees

Sector

Healthcare Facilities & Services

More about the company